Acrivon Therapeutics, Inc. (ACRV) insider trading

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Mary Miller

Chief Legal Officer

—

$943.92 (1)

−$943.92

81,202

0.1895%

$149.41K

+113.0%

Perceptive Advisors LLC entity

10% owner

—

3,104,139

7.24%

$5.71M

−42.1%

Peter Blume-Jensen

President and CEO

—

2,615,911

6.10%

$4.81M

−4.5%

Eric Devroe

Chief Operating Officer

—

146,349

0.3415%

$269.28K

+113.7%

Adam D. Levy

Chief Financial Officer

—

66,008

0.1540%

$121.45K

+395.7%

Erick Gamelin

Chief Development Officer

—

52,592

0.1227%

$96.77K

+202.9%

Mansoor Raza Mirza

Chief Medical Officer

—

38,817

0.0906%

$71.42K

—

Michaela Levin

Chief Business Officer

—

30,000

0.0700%

$55.20K

—

Rasmus Holm-Jorgensen

Chief Financial Officer

—

26,088

0.0609%

$48.00K

−3.0%

Katharine Peterson

Chief Accounting Officer

—

18,033

0.0421%

$33.18K

+289.1%

Ra Capital Management, L.p. entity

Director

—

9,366

0.0219%

$17.23K

—

Derek DiRocco

Director

—

9,366

0.0219%

$17.23K

—

Santhosh Palani

Director

—

9,366

0.0219%

$17.23K

—

Ivana Magovcevic-Liebisch

Director

—

9,366

0.0219%

$17.23K

—

Michael John Tomsicek

Director

—

9,366

0.0219%

$17.23K

—

Sharon Shacham

Director

—

9,366

0.0219%

$17.23K

—

Charles M Baum

Director

—

9,366

0.0219%

$17.23K

—

Acrivon Therapeutics, Inc.

What the insiders did Net selling

By person